| 1. Study design appropriate? |
|
|
| 2.Are CONSORT guidelines followed |
|
|
| 3. Adequate description of study participants? |
|
|
| 4. is randomisation adequate? |
|
|
| 5. Is there placebo control and is blinding adequate? |
|
|
| 6. Are details of the study medication given |
|
|
| 7. Is change in maternal vitamin D status measured? |
|
|
| 8.Are details of the assay given? |
|
|
| 9. Measurements of outcomes reliably ascertained? |
|
|
| 10. Measurements of later outcomes objective? |
|
|
| 11. Measures of vitamin D intake/ 25(OH)-vitamin D, bone outcomes eg BMD rounded |
|
|
| 12. Consideration for the effects of important confounding factors? (e.g. season, sunlight exposure, calcium intake, maternal compliance, infant feeding) |
|
|
| 13. What proportion of the cohort completed the trial |
|
|
| 14. info on non-participants |
|
|
| 15. Analysis rigorous and appropriate? |
|
|
| 16. Sample size |
|
|
|
Overall quality rating (sum of scores): |
|
|
|
f. Study results – free text, to consider cohort details, associations found, any additional quality comments |
|